Trust Company of Toledo’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.61M Buy
149,751
+6,809
+5% +$178K 0.3% 73
2026
Q1
$4.01M Sell
142,942
-1,229
-0.9% -$32.7K 0.38% 64
2025
Q4
$3.59M Sell
144,171
-11,570
-7% -$292K 0.35% 64
2025
Q3
$3.97M Buy
155,741
+1,811
+1% +$44.7K 0.4% 61
2025
Q2
$3.73M Sell
153,930
-416
-0.3% -$9.7K 0.41% 62
2025
Q1
$3.91M Buy
154,346
+10,713
+7% +$280K 0.52% 50
2024
Q4
$3.81M Sell
143,633
-3,260
-2% -$88.4K 0.5% 53
2024
Q3
$4.25M Buy
146,893
+4,955
+3% +$145K 0.58% 47
2024
Q2
$3.97M Buy
141,938
+8,567
+6% +$236K 0.57% 45
2024
Q1
$3.7M Buy
133,371
+26,018
+24% +$722K 0.58% 47
2023
Q4
$3.09M Sell
107,353
-15,476
-13% -$468K 0.53% 52
2023
Q3
$4.07M Buy
122,829
+2,567
+2% +$90.8K 0.8% 34
2023
Q2
$4.41M Buy
120,262
+6,798
+6% +$265K 0.75% 38
2023
Q1
$4.63M Buy
113,464
+960
+0.9% +$41.5K 0.83% 34
2022
Q4
$5.76K Buy
112,504
+455
+0.4% +$21.8K 1.09% 23
2022
Q3
$4.9M Buy
112,049
+3,220
+3% +$156K 0.95% 27
2022
Q2
$5.71M Buy
108,829
+203
+0.2% +$10.3K 1% 26
2022
Q1
$5.62M Sell
108,626
-1,335
-1% -$69.3K 0.86% 31
2021
Q4
$6.49M Sell
109,961
-1,595
-1% -$79K 0.97% 27
2021
Q3
$4.8M Buy
111,556
+3,654
+3% +$162K 0.78% 33
2021
Q2
$4.23M Sell
107,902
-705
-0.6% -$27.4K 0.71% 34
2021
Q1
$3.94M Buy
108,607
+15,036
+16% +$534K 0.71% 36
2020
Q4
$3.44M Buy
93,571
+2,434
+3% +$89.3K 0.67% 37
2020
Q3
$3.17M Sell
91,137
-3,286
-3% -$115K 0.71% 35
2020
Q2
$2.93M Buy
94,423
+6,423
+7% +$218K 0.7% 36
2020
Q1
$2.73M Buy
88,000
+649
+0.7% +$22.1K 0.75% 34
2019
Q4
$3.25M Buy
87,351
+6,764
+8% +$241K 0.76% 37
2019
Q3
$2.75M Sell
80,587
-523
-0.6% -$19K 0.67% 38
2019
Q2
$3.33M Buy
81,110
+705
+0.9% +$28K 0.83% 32
2019
Q1
$3.24M Buy
80,405
+1,193
+2% +$47.8K 0.83% 35
2018
Q4
$3.28M Sell
79,212
-150
-0.2% -$6.23K 0.92% 32
2018
Q3
$3.32M Buy
79,362
+699
+0.9% +$26.9K 0.85% 36
2018
Q2
$2.71M Sell
78,663
-1,137
-1% -$38.9K 0.72% 38
2018
Q1
$2.69M Sell
79,800
-3,762
-5% -$129K 0.71% 38
2017
Q4
$2.87M Sell
83,562
-91
-0.1% -$3.1K 0.71% 42
2017
Q3
$2.83M Sell
83,653
-1,544
-2% -$49.6K 0.72% 39
2017
Q2
$2.71M Buy
85,197
+3,464
+4% +$109K 0.7% 39
2017
Q1
$2.65M Sell
81,733
-1,164
-1% -$36.7K 0.72% 39
2016
Q4
$2.56M Buy
82,897
+992
+1% +$30.3K 0.72% 40
2016
Q3
$2.63M Buy
81,905
+1,268
+2% +$42.4K 0.75% 40
2016
Q2
$2.69M Buy
80,637
+3,305
+4% +$105K 0.78% 39
2016
Q1
$2.17M Buy
77,332
+573
+0.7% +$16.4K 0.65% 42
2015
Q4
$2.35M Sell
76,759
-4,279
-5% -$135K 0.72% 39
2015
Q3
$2.42M Sell
81,038
-8,478
-9% -$272K 0.77% 35
2015
Q2
$2.85M Buy
89,516
+7,745
+9% +$252K 0.83% 29
2015
Q1
$2.7M Buy
81,771
+1,371
+2% +$43.6K 0.81% 31
2014
Q4
$2.38M Buy
80,400
+10,917
+16% +$313K 0.72% 36
2014
Q3
$1.95M Sell
69,483
-4,393
-6% -$123K 0.64% 41
2014
Q2
$2.08M Sell
73,876
-3,314
-4% -$94.5K 0.61% 41
2014
Q1
$2.35M Buy
77,190
+16,588
+27% +$495K 0.71% 37
2013
Q4
$1.76M Buy
60,602
+4,719
+8% +$137K 0.57% 46
2013
Q3
$1.52M Buy
55,883
+23,226
+71% +$632K 0.55% 46
2013
Q2
$868K Buy
+32,657
New +$902K 0.32% 79

Other funds holding PFE

Trust Company of Toledo's PFE Position: Q2 2026 in Review

Trust Company of Toledo increased its Pfizer (PFE) stake by 4.8% in Q2 2026, buying an estimated $178K and bringing the position to 149,751 shares worth $3.61M. The position accounts for 0.3% of the portfolio, ranked #73.

Trust Company of Toledo first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.49M in Q4 2021. 1,218 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Trust Company of Toledo held 149,751 shares of Pfizer worth $3.61M as of Q2 2026.
  • Trust Company of Toledo bought 6,809 Pfizer shares in Q2 2026, an estimated $178K.
  • Pfizer made up 0.3% of Trust Company of Toledo's portfolio in Q2 2026, its #73 holding.
  • Trust Company of Toledo first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Trust Company of Toledo's Pfizer position peaked at $6.49M in Q4 2021.
  • 1,218 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Trust Company of Toledo's 13F filing for Q2 2026, filed 16 Jul 2026.